CDL now offers three solutions for cardiovascular imaging needs
April 23, 2024
CDL Nuclear Technologies Launches New Mobile Cardiac PET/CT Trailer
April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch…
Read More
Using two primary markers‑— coronary calcium and heart chamber size — A routine chest scan without contrast shows promise for disease detection
April 23, 2024
Artificial Intelligence Can Evaluate Cardiovascular Risk During CT Scan
April 23, 2024 — A recent study designed and implemented by investigators at Cedars-Sinai found that artificial…
Read More
Next-generation Avalus Ultra valve is Medtronic’s most advanced surgical aortic tissue valve built on 10 years of clinical experience with the Avalus valve
April 23, 2024
Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management
April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest…
Read More
A new study showed that a non-invasive imaging test can help identify patients with coronary artery blockage or narrowing who need a revascularization procedure
April 22, 2024
Novel CT Exam Reduces Need for Invasive Artery Treatment
April 22, 2024 — A new study showed that a non-invasive imaging test can help identify patients with coronary artery…
Read More
RCE Technologies, Inc. (RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heart attack detection.
April 22, 2024
RCE Technologies, Inc. Announces First-In-Human Transdermal Continuous Cardiac Biomarker Monitoring
April 22, 2024 — At the annual American College of Cardiology conference (ACC.24) in Atlanta last week, RCE…
Read More
Second major trial for atrial shunt therapy demonstrates importance of patient selection
April 22, 2024
Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data
April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the…
Read More
New evidence published in Heart Rhythm underpins why the blanking period should be shortened
April 18, 2024
Shorten the Blanking Period After Atrial Fibrillation Ablation, Experts Say
April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period…
Read More
AI-enriched platform transforms disparate data into actionable insights for care providers and partners, boosts patient engagement and access to care for improved outcomes at lower cost
April 18, 2024
Karoo Health Launches Proprietary Technology Platform Kohere.ai to Supercharge Its Cardiac Value-based Care Model
April 18, 2024 — Karoo Health, the only operational provider of cardiac value-based care (VBC) enablement with…
Read More
AB-1002 is being studied for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms
April 18, 2024
AskBio Receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure
April 18, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently…
Read More
Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered stent system, which has been on the market for twenty years and recently received premarket approval for treatment of iliac arterial occlusive disease
April 17, 2024
Getinge Enters into Commercial Distribution Agreement with Cook Medical for iCast Covered Stent System in the United States
April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered…
Read More
Mike Black
April 17, 2024
CPR-Therapeutics, Inc. Names Mike Black as Chief Strategy Officer
April 17, 2024 —CPR Therapeutics, Inc. (CPR-T), an early-stage medtech startup funded by the N.I.H and N.S.F to develop…
Read More
Complications during procedures only contributed to death in about 20% of cases
April 16, 2024
Around 10% of Deaths from Coronary Stenting, Balloon Angioplasty are Preventable
April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally…
Read More
Investigational technology designed for patients undergoing emerging large bore percutaneous catheter-based venous interventional procedures
April 16, 2024
Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System
April 16, 2024 — Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel…
Read More
Investigational technology designed for patients undergoing emerging large bore percutaneous catheter-based venous interventional procedures
April 16, 2024
CVRx Announces Availability of Additional Data Supporting Long-term Benefits of Barostim
April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional…
Read More
Abbott/Thoratec Corp. is recalling HeartMate II and HeartMate 3 Left Ventricular Assist System (LVAS) due to an issue called Extrinsic Outflow Graft Obstruction, (EOGO).
April 15, 2024
FDA Announces Recalls of Abbott/Thoratec Corp. Heartmate II and Heartmate 3 Left Ventricular Assist System (LVAS) Due to Long-term Buildup of biological material Causing an Obstruction
April 15, 2024 —  The U.S. Food and Drug Administration (FDA) announced Abbott/Thoratec Corp. is recalling HeartMate II…
Read More
The Acolyte System is intended to provide interventional cardiologists with a more reliable and predictable tool to facilitate revascularization of chronic total occlusion (CTO)
April 12, 2024
Simpson Interventions Receives FDA Breakthrough Device Designation for Acolyte Image Guided Crossing and Re-Entry Catheter System
April 12, 2024 — Simpson Interventions, Inc., a pioneering medical technology company specializing in cardiovascular…
Read More
New Data Presented at the European Heart Rhythm Association Conference Marks First Scientific Presentation on HeartBeam AI, the Company’s Deep Learning Technology
April 12, 2024
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias
April 12, 2024 —  HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the power…
Read More
University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that contributes to the greater incidence of heart failure in men.
April 12, 2024
New Advance Against a Form of Heart Failure Prevalent in Men
April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that…
Read More
Trial bolsters evidence that less invasive strategy is safe and effective in younger, lower-risk patients
April 11, 2024
TAVR Found Non-Inferior to SAVR for Low-Risk Patients
April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated…
Read More
Results from the IVUS-DCB trial were recently presented at the American College of Cardiology Annual Scientific Session, ACC.24.
April 11, 2024
Intravascular Ultrasound Outperforms Angiography for Peripheral Artery Disease Treatment
April 11, 2024 — One-year success rates from angioplasty procedures to open clogged arteries in the legs were…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now